Price $300.30 |
Market Cap
24.25B
|
Sector Health Care |
Div. Growth
5.60%
|
|
P/E
45.4
|
P/B
8.68
|
P/S
8.51
|
Dividend %
0.20%
|
|
P/CF
149.0
|
P/FCF
69.5
|
Op. Cash Flow
768.2K
|
FCF
4.8
|
|
Op. Margin
22.00%
|
Net Margin
19.10%
|
ROE
20.20%
|
ROI
19.40%
|
|
ROA
15.20%
|
EPS Growth
-10.90%
|
Current Ratio
3.7
|
Debt/Equity
7.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
